New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Additionally, the concept of sarcopenic obesity—where individuals have both excess body fat and low muscle mass—has gained attention in geriatric research. A consensus statement from leading ...

She was the classic case of being skinny fat, a person who has normal body weight but has a high percentage of body fat ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

New Delhi, May 27 (ANI): According to new research by Juntendo University, scientists linked dementia in elderly people with sarcopenic obesity. The findings of the research were published in the ...

Villareal, a professor at the Baylor College of Medicine in Houston, has told the National Institute of Ageing the “most ...

The Phase 2b, multicenter, double-blind, placebo-controlled, randomized, dose-finding clinical trial is designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a ...

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...